Lars Fruergaard Jørgensen betegnes af magasinet Fortune som den 29. mest magtfulde erhvervsleder i verden. Novo Nordisks ...
There's been pressure put on Novo Nordisk to lower the cost of Ozempic and Wegovy. In late September, company CEO Lars ...
Lars Fruergaard Jørgensen betegnes af magasinet Fortune som den 29. mest magtfulde erhvervsleder i verden Lars Fruergaard Jørgensen er af det amerikanske magasin Forbes blev udpeget som en af ...
Lars Fruergaard Jørgensen er af det amerikanske magasin Forbes blev udpeget som en af verdens mest indflydelsesrige erhvervsledere. (Arkivfoto). Mariam Zuhaib/Ritzau Scanpix Novo Nordisks succes ...
Lars Fruergaard Jørgensen betegnes af magasinet Fortune som den 29. mest magtfulde erhvervsleder i verden. Novo Nordisks succes inden for udvikling af behandlinger af både diabetes og svær ...
While Novo Nordisk’s CEO Lars Fruergaard Jørgensen has defended the high U.S. prices of the company’s blockbuster drugs, ...
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
Novo Nordisk’ chief executive Lars Fruergaard Jørgensen has agreed to appear at a Senate hearing later this year to defend the pricing of the group’s semaglutide-based therapies for diabetes ...
Stepping into this turbulent environment is Novo Nordisk’s new CEO Lars Fruergaard Jørgensen. A 25-year insider at Novo Nordisk, Jørgensen took the helm in January this year, and brought in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback